Text NEWBIE20 to (312) 846-1629 to claim your offer and reserve your spot today
Petrelintide (ZP8396) Petrelintide (ZP8396) is a novel SC-administered, long-acting amylin analog, developed by Zealand Pharma (Sborg, Denmark), a peptide drug discovery and development company, which is currently in early-stage clinical trials (phase 1 clinical trials: ClinicalTrials.gov Identifier NCT05511025, NCT05096598 and NCT05613387) [116]
At Wellness Drips, we approach IV therapy with a scientific foundation
Accelerated Healing of Tendon and Ligament Injuries Tendon and ligament injuries are common in performance horses and often require months of rest and rehabilitation
Microneedling occupies a unique space in skin care it delivers real, measurable results with minimal downtime, a strong safety profile, and lower cost compared to laser treatments
If you are considering or currently using BPC-157 or TB-500, we recommend seeking medical advice first to avoid risking complications